Mehmet A Baysal
6PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jun 28, 2025
Phase 1 study of zavondemstat (TACH101), a first-in-class KDM4 inhibitor, in patients with advanced solid tumors.Apostolia M Tsimberidou, Farshid Dayyani, David Sommerhalder
|Jan 31, 2025
Convergence of evolving artificial intelligence and machine learning techniques in precision oncology.Elena Fountzilas, Tillman Pearce, Mehmet A Baysal
|Sep 14, 2024
Synergistic Cytotoxicity of Histone Deacetylase and Poly-ADP Ribose Polymerase Inhibitors and Decitabine in Breast and Ovarian Cancer Cells: Implications for Novel Therapeutic Combinations.Benigno C Valdez, Apostolia M Tsimberidou, Bin Yuan
|Dec 19, 2023
Autologous engineered T cell receptor therapy in advanced cancer.Apostolia M Tsimberidou, Mehmet A Baysal, Abhijit Chakraborty
|Oct 16, 2023
Molecular tumour boards - current and future considerations for precision oncology.Apostolia M Tsimberidou, Michael Kahle, Henry Hiep Vo
|Apr 13, 2023
Precision Oncology: Evolving Clinical Trials across Tumor Types.I-Wen Song, Henry Hiep Vo, Ying-Shiuan Chen
Pageof 1
